View Older Stories View More Recent Stories

Nov 10, 2021 08:00AM Cue Biopharma to Present at Two Upcoming Investor Healthcare Conferences in November
Nov 10, 2021 08:00AM Cue Biopharma to Present at Two Upcoming Investor Healthcare Conferences in November
Oct 21, 2021 12:00PM Cue Biopharma Announces Publication in The Journal of Clinical Investigation Highlighting Immuno-STAT Biologics for the Treatment of Chronic Infectious Diseases
Oct 21, 2021 12:00PM Cue Biopharma Announces Publication in The Journal of Clinical Investigation Highlighting Immuno-STAT Biologics for the Treatment of Chronic Infectious Diseases
Oct 4, 2021 08:00AM Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 36th Anniversary Annual Meeting
Oct 4, 2021 08:00AM Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 36th Anniversary Annual Meeting
Sep 28, 2021 08:06AM Cue Biopharma Inc. (CUE) Announces Publication in Nature Journal, Scientific Reports, of Immunotherapeutic Platforms Immuno-STAT and Neo-STAT
Sep 28, 2021 08:00AM Cue Biopharma Announces Publication in Nature Journal, Scientific Reports, of Immunotherapeutic Platforms Immuno-STAT and Neo-STAT
Sep 28, 2021 08:00AM Cue Biopharma Announces Publication in Nature Journal, Scientific Reports, of Immunotherapeutic Platforms Immuno-STAT and Neo-STAT
Sep 21, 2021 08:00AM Cue Biopharma (CUE) Granted U.S. Patents on Lead Clinical Program Novel Drug Product Candidate CUE-101
Sep 21, 2021 08:00AM Cue Biopharma Granted U.S. Patents on Lead Clinical Program Novel Drug Product Candidate CUE-101
Sep 21, 2021 08:00AM Cue Biopharma Granted U.S. Patents on Lead Clinical Program Novel Drug Product Candidate CUE-101
Sep 9, 2021 08:00AM Cue Biopharma to Present at Two Upcoming Investor Healthcare Conferences
Sep 9, 2021 08:00AM Cue Biopharma to Present at Two Upcoming Investor Healthcare Conferences
Aug 17, 2021 04:01PM Cue Biopharma Reports Second Quarter 2021 Results, Recent Data Updates of CUE-101 Phase 1 Dose Escalation and Expansion Study, Platform Progress and Business Highlights
Aug 17, 2021 04:01PM Cue Biopharma Reports Second Quarter 2021 Results, Recent Data Updates of CUE-101 Phase 1 Dose Escalation and Expansion Study, Platform Progress and Business Highlights
Aug 10, 2021 08:00AM Cue Biopharma to Host Business Update Call and Webcast
Aug 10, 2021 08:00AM Cue Biopharma to Host Business Update Call and Webcast
Aug 3, 2021 08:00AM Cue Biopharma to Present Corporate Update at the Upcoming BTIG Virtual Biotechnology Conference
Aug 3, 2021 08:00AM Cue Biopharma to Present Corporate Update at the Upcoming BTIG Virtual Biotechnology Conference
Jun 14, 2021 08:00AM Cue Biopharma to Present at the Upcoming JMP Securities Life Sciences Conference
Jun 14, 2021 08:00AM Cue Biopharma to Present at the Upcoming JMP Securities Life Sciences Conference
Jun 10, 2021 08:00AM Cue Biopharma Announces First Patient Dosed in Part B Patient Expansion of CUE-101 Phase 1 Monotherapy Trial in HPV+ Second Line and Beyond HNSCC
Jun 10, 2021 08:00AM Cue Biopharma Announces First Patient Dosed in Part B Patient Expansion of CUE-101 Phase 1 Monotherapy Trial in HPV+ Second Line and Beyond HNSCC
Jun 3, 2021 08:30AM Cue Biopharma to Present at the 2021 Federation of Clinical Immunology Societies (FOCIS) Virtual Annual Meeting
Jun 3, 2021 08:30AM Cue Biopharma to Present at the 2021 Federation of Clinical Immunology Societies (FOCIS) Virtual Annual Meeting
May 26, 2021 08:00AM Cue Biopharma to Present a Corporate and Clinical Progress Update at the Upcoming Jefferies Virtual Healthcare Conference
May 26, 2021 08:00AM Cue Biopharma to Present a Corporate and Clinical Progress Update at the Upcoming Jefferies Virtual Healthcare Conference
May 17, 2021 04:01PM Cue Biopharma Reports First Quarter 2021 Results, Recent Updates of CUE-101 Phase 1 Dose Escalation Study, Platform Progress and Business Highlights
May 17, 2021 04:01PM Cue Biopharma Reports First Quarter 2021 Results, Recent Updates of CUE-101 Phase 1 Dose Escalation Study, Platform Progress and Business Highlights
May 10, 2021 10:00AM Cue Biopharma to Host Business Update Call and Webcast
May 10, 2021 10:00AM Cue Biopharma to Host Business Update Call and Webcast
May 10, 2021 08:03AM Cue Biopharma (CUE) Reports Confirmed Partial Response in Ongoing Phase 1 Monotherapy Study of CUE-101 in Late Stage Second Line and Beyond Patients with HPV+ Recurrent/Metastatic Head and Neck Cancer
May 10, 2021 08:00AM Cue Biopharma Reports Confirmed Partial Response (PR) in Ongoing Phase 1 Monotherapy Study of CUE-101 in Late Stage Second Line and Beyond Patients with HPV+ Recurrent/Metastatic Head and Neck Cancer
May 10, 2021 08:00AM Cue Biopharma Reports Confirmed Partial Response (PR) in Ongoing Phase 1 Monotherapy Study of CUE-101 in Late Stage Second Line and Beyond Patients with HPV+ Recurrent/Metastatic Head and Neck Cancer
May 6, 2021 08:00AM Cue Biopharma to Present at the 2021 Frontiers in Cancer Immunotherapy Conference
May 6, 2021 08:00AM Cue Biopharma to Present at the 2021 Frontiers in Cancer Immunotherapy Conference
Mar 16, 2021 04:01PM Cue Biopharma Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Business Highlights
Mar 16, 2021 04:01PM Cue Biopharma Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Business Highlights
Mar 15, 2021 08:00AM Cue Biopharma to Present Corporate Overview and Clinical Progress at the Upcoming Oppenheimer 31st Annual Healthcare Conference
Mar 15, 2021 08:00AM Cue Biopharma to Present Corporate Overview and Clinical Progress at the Upcoming Oppenheimer 31st Annual Healthcare Conference
Mar 9, 2021 08:00AM Cue Biopharma to Host Business Update Call and Webcast
Mar 9, 2021 08:00AM Cue Biopharma to Host Business Update Call and Webcast
Mar 1, 2021 08:00AM Cue Biopharma to Present at the Cowen 41st Annual Health Care Conference
Mar 1, 2021 08:00AM Cue Biopharma to Present at the Cowen 41st Annual Health Care Conference
Feb 25, 2021 08:00AM Cue Biopharma Enhances Scientific Advisory Board with Appointments of Immunology and Immunotherapy Experts Dr. Abul K. Abbas and Dr. Michael Kalos
Feb 25, 2021 08:00AM Cue Biopharma Enhances Scientific Advisory Board with Appointments of Immunology and Immunotherapy Experts Dr. Abul K. Abbas and Dr. Michael Kalos
Feb 22, 2021 08:00AM Cue Biopharma to Present at the 7th Annual Immuno-Oncology 360° Conference
Feb 22, 2021 08:00AM Cue Biopharma to Present at the 7th Annual Immuno-Oncology 360° Conference
Feb 17, 2021 08:00AM Cue Biopharma Announces Appointment of Matteo Levisetti, M.D. as Senior Vice President of Clinical Development
View More Recent Stories View Older Stories